Dashboard
Manage Tickers

WVEWave Life Sciences Ltd.

Nasdaq wavelifesciences.com


$ 5.78 $ -0.18 (-3.1 %)    

Tuesday, 17-Sep-2024 15:39:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 472.89 $ -3.08 (-0.65 %)
DIA $ 416.71 $ -1.28 (-0.31 %)
SPY $ 562.34 $ -2.79 (-0.49 %)
TLT $ 100.93 $ -0.46 (-0.45 %)
GLD $ 237.41 $ -0.57 (-0.24 %)
$ 5.98
$ 5.96
$ 5.77 x 200
$ 5.79 x 121
$ 5.77 - $ 6.03
$ 3.50 - $ 7.67
532,880
na
745.93M
$ 0.01
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-10-2024 03-31-2024 10-Q
3 03-06-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 05-03-2023 03-31-2023 10-Q
7 03-23-2023 12-31-2022 10-K
8 11-10-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-12-2022 03-31-2022 10-Q
11 03-03-2022 12-31-2021 10-K
12 11-10-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 05-13-2021 03-31-2021 10-Q
15 03-04-2021 12-31-2020 10-K
16 11-09-2020 09-30-2020 10-Q
17 08-10-2020 06-30-2020 10-Q
18 05-11-2020 03-31-2020 10-Q
19 03-02-2020 12-31-2019 10-K
20 11-05-2019 09-30-2019 10-Q
21 08-06-2019 06-30-2019 10-Q
22 05-10-2019 03-31-2019 10-Q
23 03-01-2019 12-31-2018 10-K
24 11-09-2018 09-30-2018 10-Q
25 08-09-2018 06-30-2018 10-Q
26 05-09-2018 03-31-2018 10-Q
27 03-12-2018 12-31-2017 10-K
28 11-09-2017 09-30-2017 10-Q
29 08-09-2017 06-30-2017 10-Q
30 05-10-2017 03-31-2017 10-Q
31 03-16-2017 12-31-2016 10-K
32 11-09-2016 09-30-2016 10-Q
33 08-15-2016 06-30-2016 10-Q
34 05-16-2016 03-31-2016 10-Q
35 03-30-2016 12-31-2015 10-K
36 12-17-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jp-morgan-initiates-coverage-on-wave-life-sciences-with-overweight-rating-announces-price-target-of-10
JP Morgan Initiates Coverage On WAVE Life ...
09/09/2024 12:27:35

JP Morgan initiates coverage on WAVE Life Sciences (NASDAQ:WVE) with a Overweight rating and announces Price Target of $10.

gene-editing-korro-bios-preclinical-data-best-in-class-analyst-initiates-with-outperform-rating
Gene Editing Korro Bio's Preclinical Data ...
08/14/2024 18:21:10

William Blair initiates coverage on Korro Bio highlighting its innovative RNA editing platform, ADAR-based OPERA. The analyst r...

wave-life-sciences-shares-are-trading-higher-after-the-company-announced-that-the-fda-has-granted-rare-pediatric-disease-designation-to-wve-n531-for-the-treatment-of-duchenne-muscular-dystrophy
Wave Life Sciences shares are trading high...
08/12/2024 13:19:40

wave-life-sciences-announces-fda-has-granted-rare-pediatric-disease-designation-to-wve-n531-for-treatment-of-duchenne-muscular-dystrophy
Wave Life Sciences Announces FDA Has Grant...
08/12/2024 12:31:05

deep-dive-into-wave-life-sciences-stock-analyst-perspectives-4-ratings
Deep Dive Into WAVE Life Sciences Stock: A...
08/09/2024 16:00:57

jones-trading-initiates-coverage-on-wave-life-sciences-with-buy-rating-announces-price-target-of-12
Jones Trading Initiates Coverage On WAVE L...
08/09/2024 12:25:55

Jones Trading analyst Catherine Novack initiates coverage on WAVE Life Sciences (NASDAQ:WVE) with a Buy rating and announces...

wave-life-sciences-q2-2024-gaap-eps-025-misses-021-estimate-sales-19692m-miss-24335m-estimate
WAVE Life Sciences Q2 2024 GAAP EPS $(0.25...
08/08/2024 11:35:01

WAVE Life Sciences (NASDAQ:WVE) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $...

what-analysts-are-saying-about-wave-life-sciences-stock
What Analysts Are Saying About WAVE Life S...
06/26/2024 17:00:43

hc-wainwright--co-reiterates-buy-on-wave-life-sciences-maintains-15-price-target
HC Wainwright & Co. Reiterates Buy on WAVE...
06/26/2024 12:21:00

HC Wainwright & Co. analyst Andrew Fein reiterates WAVE Life Sciences (NASDAQ:WVE) with a Buy and maintains $15 price ta...

worthington-enterprises-posts-downbeat-results-joins-taysha-gene-therapies-general-mills-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
Worthington Enterprises Posts Downbeat Res...
06/26/2024 11:36:28

mizuho-reiterates-outperform-on-wave-life-sciences-maintains-19-price-target
Mizuho Reiterates Outperform on WAVE Life ...
06/25/2024 16:40:05

Mizuho analyst Salim Syed reiterates WAVE Life Sciences (NASDAQ:WVE) with a Outperform and maintains $19 price target.

whats-going-on-with-wave-life-sciences-stock-on-tuesday
What's Going On With Wave Life Sciences St...
06/25/2024 13:37:07

Wave Life Sciences reports Phase 1b/2a SELECT-HD trial results for WVE-003 in Huntington's disease, demonstrates promise as...

wave-life-sciences-announced-results-from-its-phase-1b2a-select-hd-trial-of-wve-003-for-huntingtons-disease-demonstrating-mutant-huntingtin-lowering-of-46-with-preservation-of-wild-type-huntingtin
Wave Life Sciences Announced Results From ...
06/25/2024 11:35:50

Statistically significant, potent, and durable allele-selective silencing: 46% mean reduction in CSF mutant huntingtin (mHTT)...

wave-life-sciences-stock-a-deep-dive-into-analyst-perspectives-5-ratings
WAVE Life Sciences Stock: A Deep Dive Into...
05/15/2024 13:01:00

wells-fargo-initiates-coverage-on-wave-life-sciences-with-overweight-rating-announces-price-target-of-11
Wells Fargo Initiates Coverage On WAVE Lif...
05/15/2024 12:19:13

Wells Fargo analyst Tiago Fauth initiates coverage on WAVE Life Sciences (NASDAQ:WVE) with a Overweight rating and announces...

wave-life-sciences-q1-eps-024-misses-021-estimate-sales-1254m-miss-2295m-estimate
WAVE Life Sciences Q1 EPS $(0.24) Misses $...
05/09/2024 11:34:03

WAVE Life Sciences (NASDAQ:WVE) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $...

wave-life-sciences-announces-approval-of-first-clinical-trial-application-for-restoraation-2-trial-of-wve-006-in-individuals-with-alpha-1-antitrypsin-deficiency
Wave Life Sciences Announces Approval Of F...
04/30/2024 12:40:14

Wave Life Sciences Ltd. (NASDAQ:WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA me...

Core News & Articles
As Part Of Wave Life Sciences' Ongoing Col...
04/23/2024 14:22:56

GSK has selected the first two programs to advance following achievement of target validation, marking transition to next pha...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
04/04/2024 20:31:22

truist-securities-reiterates-buy-on-wave-life-sciences-maintains-17-price-target
Truist Securities Reiterates Buy on WAVE L...
04/01/2024 13:08:09

Truist Securities analyst Joon Lee reiterates WAVE Life Sciences (NASDAQ:WVE) with a Buy and maintains $17 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION